City Clinical Hospital n.a. D.D.Pletnev

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations	Urothelial Cancer	Active, not recruiting	Phase 3	2026-09-25		NCT03390504
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer	Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urothelial carcinoma	Active, not recruiting	Phase 1 / Phase 2	2026-08-28		NCT03473743

Clinical trials